Scientists test drug combos to shrink tumors before breast cancer surgery
NCT ID NCT00295893
Summary
This study is testing two different combinations of chemotherapy drugs, given before surgery, to see which is better at shrinking breast tumors. For some patients, a targeted drug called trastuzumab (Herceptin) is added to one of the combinations. The goal is to reduce the amount of cancer present at surgery, which may improve long-term outcomes. The study enrolled 121 people with stage II or III breast cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010-3000, United States
Conditions
Explore the condition pages connected to this study.